It’s one of the most devastating and economically damaging pig diseases in the world: Porcine circovirus associated disease (PCVAD). It can strike early or appear in a late form. And once it strikes, the consequences are never good.
Protect your herd from wean to finish with the only single-dose circo vaccine for pigs three weeks of age or older: Ingelvac CircoFLEX® from Boehringer Ingelheim.
Pneumonia, PMWS, enteritis, respiratory disease, porcine dermatitis and nephropathy syndrome… those are just some of the diseases caused by PCV2 that can affect pigs suddenly if left unprotected. The result?
Field trials, laboratory studies and experience collected from over 100 million vaccinated pigs worldwide, prove the high level of efficacy against PCVAD.
In a controlled US field trial, pigs vaccinated at three weeks had a significant decrease in mortality. Average daily gain and final weights were also significantly higher than non-vaccinated pigs.3
The economic benefits of Ingelvac CircoFLEX are easy to see, even in subclinical situations. Higher weight gains. Fewer culls. Reduced mortality. Better carcass traits. And the results are even more dramatic in clinical situations.
1. Kolb, J., Diaz, E., AASV, March 2008.
2. Christmas, R., Kolb, J., Ingelvac CircoFLEX Symposium, September 2007, St. Paul, USA.
3. Cline, G., Wilt, V., Diaz, E., Efficacy of Ingelvac CircoFLEX in pigs vaccinated at 3 and 6 weeks of age in a PRRS and Mycoplasma hyopneumoniae-negative production system, Leman Conference, 2007.
4. Waddell, J., Field evaluation of Ingelvac CircoFLEX on growth performance of pigs in a subclinical PCVAD herd, World Pork Expo, 2009.